We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
A smartphone game developed by doctors in Kenya and Oxford provides vital emergency care training to African healthcare workers.
Celleron Therapeutics is developing personalised medicine for cancer patients. The company has announced results from its first human trial in patients at Oxford’s Churchill Hospital with advanced treatment-resistant aggressive cancer.
Nasdaq-listed Oxford spinout Summit Therapeutics has hit its first research milestone as part of a multiyear strategic alliance with the University of Oxford. The collaboration is focussed on developing future-generation utrophin modulators for the potential treatment of all patients with the progressive muscle wasting disorder Duchenne Muscular Dystrophy.
Summit Therapeutics and Oxford have announced a multi-year extension of their strategic alliance for the development of utrophin modulators to treat Duchenne Muscular Dystrophy.
Perspectum announced today it has been given US FDA clearance to market its test for diagnosing and measuring liver disease.
Oxford University Innovation spinout OrganOx has received CE mark certification for its OrganOx metra device, which improves the success of liver transplantation.
with
Outside London, it is arguable that no other region has had more of an effect on the evolution of the UK than Oxford. From custodians of the English language to leaders of the country, Oxford has continued to have a major impact on the shape and destiny of the British people.
